Effect of specialist decision-making on treatment strategies for colorectal liver metastases

British Journal of Surgery

Volumn 99, Issue 9, 2012, Pages 1263-1269

  Jones, R P ^a,b   Vauthey, J N ^e   Adam, R ^f   Rees, M ^c   Berry, D ^d   Jackson, R ^a   Grimes, N ^b   Fenwick, S W ^b   Poston, G J ^b   Malik, H Z ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^c BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; COLORECTAL TUMOR; COMPARATIVE STUDY; CONSENSUS; DECISION MAKING; FEMALE; GASTROENTEROLOGY; HUMAN; LIVER TUMOR; MALE; MEDICAL ERROR; METASTASIS; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; PALLIATIVE THERAPY; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; CONSENSUS; DECISION MAKING; FEMALE; GASTROENTEROLOGY; HUMANS; LIVER NEOPLASMS; MALE; MEDICAL ERRORS; MIDDLE AGED; OBSERVER VARIATION; PALLIATIVE CARE; PROSPECTIVE STUDIES;

EID: 84864677002     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8835     Document Type: Article

References (28)

1. Rougier P, Milan C, Lazorthes F, Fourtanier G, Partensky C, Baumel H, et al., Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancérologie Digestive. Br J Surg 1995; 82: 1397-1400.
2. Scheele J, Stang R, Altendorf-Hofmann A, Paul M,. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
3. Adam R, Vinet E,. Regional treatment of metastasis: surgery of colorectal liver metastases. Ann Oncol 2004; 15 (Suppl 4): iv103-iv106. (Pubitemid 39585320)
4. Yamada H, Kondo S, Okushiba S, Morikawa T, Katoh H,. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases. World J Surg 2001; 25: 1129-1133. (Pubitemid 32845823)
5. Crowe PJ, Yang JL, Berney CR, Erskine C, Ham JM, Fisher R, et al., Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancer. World J Surg 2001; 25: 996-1001. (Pubitemid 32747646)
6. Mala T, Bøhler G, Mathisen O, Bergan A, Søreide O,. Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 2002; 26: 1348-1353. (Pubitemid 36920229)
7. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, et al., Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-766. (Pubitemid 34547293)
8. Nordlinger B, Vaillant JC, Guiguet M, Balladur P, Paris F, Bachellier P, et al., Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Française de Chirurgie. J Clin Oncol 1994; 12: 1491-1496. (Pubitemid 24206250)
9. Figueras J, Valls C, Rafecas A, Fabregat J, Ramos E, Jaurrieta E,. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg 2001; 88: 980-985. (Pubitemid 34015581)
10. Rees M, Tekkis PP, Welsh FKS, O'Rourke T, John TG,. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247: 125-135.
11. Wang JY, Chiang JM, Jeng LB, Changchien CR, Chen JS, Hsu KC,. Resection of liver metastases from colorectal cancer: are there any truly significant clinical prognosticators? Dis Colon Rectum 1996; 39: 847-851. (Pubitemid 26332459)
12. Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C,. Patient selection for hepatic resection of colorectal metastases. Arch Surg 1996; 131: 322-329. (Pubitemid 26078821)
13. Ambiru S, Miyazaki M, Isono T, Ito H, Nakagawa K, Shimizu H, et al., Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 1999; 42: 632-639. (Pubitemid 29228409)
14. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP,. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110: 13-29.
15. Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H,. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 2003; 238: 871-883.
16. Adam R, Wicherts DA, de Haas RJ, Ciacio O, Lévi F, Paule B, et al., Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 2009; 27: 1829-1835.
17. Adam R, Frilling A, Elias D, Laurent C, Ramos E, Capussotti L, et al., Liver resection of colorectal metastases in elderly patients. Br J Surg 2010; 97: 366-376.
18. Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, Hartmann JT, et al., Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 2010; 11: 38-47.
19. Garufi C, Torsello A, Tumolo S, Ettorre GM, Zeuli M, Campanella C, et al., Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial. Br J Cancer 2010; 103: 1542-1547.
20. Masi G, Loupakis F, Salvatore L, Fornaro L, Cremolini C, Cupini S, et al., Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial. Lancet Oncol 2010; 11: 845-852.
21. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, et al., Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001; 8: 347-353. (Pubitemid 32422861)
22. Folprecht G, Grothey A, Alberts S, Raab H-R, Köhne C-H,. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005; 16: 1311-1319. (Pubitemid 41158476)
23. Nordlinger B, Van Cutsem E, Rougier P, Köhne C-H, Ychou M, Sobrero A, et al.,; European Colorectal Metastases Treatment Group. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer 2007; 43: 2037-2045. (Pubitemid 47380368)
24. Morris EJ, Forman D, Thomas JD, Quirke P, Taylor EF, Fairley L, et al., Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 2010; 97: 1110-1118.
25. Vauthey JN, Pawlik TM, Ribero D, Wu T-T, Zorzi D, Hoff PM, et al., Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24: 2065-2072. (Pubitemid 46622116)
26. Grand DJ, Beland M, Noto RB, Mayo-Smith W,. Optimum imaging of colorectal metastases. J Surg Oncol 2010; 102: 909-913.
27. Ruers T, Punt C, Van Coevorden F, Pierie JP, Borel-Rinkes I, Ledermann JA, et al., Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol 2012; Mar 19. [Epub ahead of print].
28. Benoist S, Brouquet A, Penna C, Julié C, El Hajjam M, Chagnon S, et al., Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006; 24: 3939-3945. (Pubitemid 46630742)